| Consolidated & Uncosolidated Financial Highlight |
| Item |
FY2007
(March 31, 2008) |
FY2008
(March 31, 2009) |
FY2009
(March 31, 2010) |
| Unconsolidated |
Consolidated |
Unconsolidated |
Consolidated |
Unconsolidated |
Consolidated |
| Financial results |
Net sales(mil, ) |
23,200 |
28,096 |
17,996 |
22,435 |
13,333 |
17,886 |
Operating income(mil, ) |
2,922 |
3,256 |
1,687 |
2,016 |
700 |
896 |
Ordinary income(mil, ) |
3,283 |
3,602 |
1,869 |
2,029 |
889 |
1103 |
Selling, general & administrative
expenses(mil, ) |
5,258 |
7,462 |
4,617 |
6,783 |
3,852 |
6,006 |
Net income(mil, ) |
2,968 |
2,313 |
1,042 |
1,376 |
615 |
711 |
Net income per share( ) |
64.00 |
49.87 |
22.59 |
29.84 |
13.37 |
15.44 |
| Financial position |
Total assets(mil, ) |
24,893 |
26,911 |
22,149 |
23,482 |
22,495 |
24,140 |
Net assets(mil, ) |
16,474 |
16,942 |
16,538 |
16,821 |
16,824 |
17,440 |
| Ratio of shareholders' equity(%) |
66.2 |
60.8 |
74.7 |
69.2 |
74.8 |
69.4 |
Net assets per share( ) |
357.13 |
354.79 |
358.49 |
352.38 |
370.59 |
368.81 |
| ROA(%) |
13.5 |
13.3 |
4.4 |
5.5 |
2.8 |
3.0 |
| ROE(%) |
18.6 |
14.3 |
6.3 |
8.4 |
3.7 |
4.3 |
| Cash flows |
Cash flows from operating activities(mil, ) |
- |
2,685 |
- |
1,670 |
- |
1,778 |
Cash flows from investing activities(mil, ) |
- |
 1,294 |
- |
 154 |
- |
 2,081 |
Cash flows from financing activities(mil, ) |
- |
 1,610 |
- |
 710 |
- |
 438 |
Cash and cash equivalents at the
end of period(mil, ) |
- |
4,375 |
- |
5,210 |
- |
4,507 |
|
 |
| Consolidated Financial Highlight of
2008 |
 |
2008 |
|
| Item |
1Q |
2Q |
3Q |
| April 1 through June 30 |
April 1 through September 30 |
April 1 through December 31 |
| Consolidated financial
results |
Net sales(mil, ) |
3,728 |
8,232 |
12,347 |
Operating income(mil, ) |
36 |
220 |
497 |
Ordinary income(mil, ) |
84 |
350 |
671 |
Net income(mil, ) |
47 |
135 |
310 |
Net income per share( ) |
1.04 |
2.94 |
6.72 |
| Consolidated financial
position |
Total assets(mil, ) |
23,019 |
23,357 |
23,332 |
Net assets(mil, ) |
17,037 |
17,059 |
17,071 |
| Ratio of shareholders' equity(%) |
71.5 |
70.4 |
70.4 |
Net assets per share( ) |
356.80 |
356.21 |
355.87 |
| Consolidated cash flows |
Cash flows from operating activities(mil, ) |
7 |
532 |
604 |
Cash flows from investing activities(mil, ) |
1,500 |
 2,114 |
 2,013 |
Cash flows from financing activities(mil, ) |
83 |
 127 |
 77 |
Cash and cash equivalents at the
end of period(mil, ) |
3,652 |
3,537 |
3,746 |
|
 |
Net sales |
|
 |
Ordinary income/Ordinary income ratio |
|
 |
Unconsolidated |
 |
Consolidated |
 |
|
 |
 |
 |
Unconsolidated |
 |
 |
Consolidated |
 |
|
|
|
 |
|
 |
Net income/Net income ratio |
|
 |
Selling, general & administrative expenses |
|
 |
Unconsolidated |
 |
Consolidated |
 |
|
 |
 |
 |
Unconsolidated |
 |
 |
Consolidated |
 |
|
|
|
 |
|
 |
Ratio of shareholders' equity(Unconsolidated) |
|
 |
Ratio of shareholders' equity(Consolidated) |
|
 |
 |
Unconsolidated |
 |
 |
Gross capital |
 |
|
 |
 |
 |
Consolidated |
 |
 |
Gross capital |
 |
|
|
|
 |
|
 |
Net income per share |
|
 |
Net assets per share |
|
 |
Unconsolidated |
 |
Consolidated |
 |
|
 |
 |
Unconsolidated |
 |
Consolidated |
 |
|
|
|
 |
|
 |
ROA |
|
 |
ROE |
|
 |
Unconsolidated |
 |
Consolidated |
 |
|
 |
 |
Unconsolidated |
 |
Consolidated |
 |
|
|
|
 |
|
|
|
|